TNFRSF1B and tuberculosis: Over the long term, this would likely ameliorate therapeutic effect by reducing clinically undesired side effects such as the recurrence of tuberculosis and the risk of malignancies or increased rates in multiple sclerosis20, which occur probably owing to the lack of TNFR2-mediated myelin regeneration9.